What is the price target for CVNA stock?
32 analysts have analysed CVNA and the average price target is 429.34 USD. This implies a price increase of 36.57% is expected in the next year compared to the current price of 314.38.
NYSE:CVNA • US1468691027
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CARVANA CO (CVNA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-16 | Needham | Reiterate | Buy -> Buy |
| 2026-02-20 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-20 | Citigroup | Maintains | Buy -> Buy |
| 2026-02-19 | DA Davidson | Maintains | Neutral -> Neutral |
| 2026-02-19 | BTIG | Maintains | Buy -> Buy |
| 2026-02-19 | Deutsche Bank | Maintains | Buy -> Buy |
| 2026-02-19 | Needham | Reiterate | Buy -> Buy |
| 2026-02-19 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-19 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2026-02-19 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-19 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-02-19 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-02-19 | B of A Securities | Maintains | Buy -> Buy |
| 2026-01-28 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-27 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-21 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-15 | BTIG | Maintains | Buy -> Buy |
| 2026-01-14 | UBS | Maintains | Buy -> Buy |
| 2026-01-13 | B of A Securities | Maintains | Buy -> Buy |
| 2025-12-23 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-12-19 | BTIG | Reiterate | Buy -> Buy |
| 2025-12-19 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-12-15 | Argus Research | Initiate | Buy |
| 2025-12-12 | Citigroup | Maintains | Buy -> Buy |
| 2025-12-11 | Barclays | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.771B -20.82% | 13.673B 26.94% | 20.322B 48.63% | 27.343B 34.55% | 33.782B 23.55% | 40.6B 20.18% | 48.445B 19.32% | 59.037B 21.86% | 76.518B 29.61% | 91.637B 19.76% | 109.771B 19.79% | |
| EBITDA YoY % growth | 288M 123.19% | 1.295B 349.65% | 2.156B 66.49% | 2.954B 37.01% | 3.838B 29.93% | 4.75B 23.76% | 5.576B 17.39% | 7.337B 31.58% | 9.235B 25.87% | 11.256B 21.88% | 13.716B 21.86% | |
| EBIT YoY % growth | -64M 95.74% | 990M 1,646.88% | 1.881B 90.00% | 2.618B 39.18% | 3.483B 33.04% | 4.359B 25.15% | 5.155B 18.26% | 6.11B 18.53% | 8.732B 42.91% | 15.81B 81.06% | 18.666B 18.06% | |
| Operating Margin | -0.59% | 7.24% | 9.26% | 9.57% | 10.31% | 10.74% | 10.64% | 10.35% | 11.41% | 17.25% | 17.00% | |
| EPS YoY % growth | -3.52 53.19% | 1.57 144.60% | 4.88 210.83% | 7.13 46.14% | 10.00 40.18% | 12.69 26.91% | 16.07 26.62% | 11.53 -28.25% | N/A | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.47 -2.32% | 1.91 49.25% | 2.08 101.86% | 1.75 65.24% | 2.61 77.03% | 3.08 61.42% | 3.27 57.15% | 2.91 65.97% | 3.28 25.78% | 3.60 16.76% | 3.71 13.63% | 3.36 15.44% |
| Revenue Q2Q % growth | 6.131B 44.87% | 6.684B 38.10% | 7.294B 29.17% | 7.218B 28.82% | 7.822B 27.58% | 8.368B 25.19% | 9.031B 23.81% | 8.911B 23.46% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 658.09M 40.92% | 766.99M 17.64% | 816.52M 7.72% | 729.19M 4.32% | 904.86M 37.50% | 1.012B 31.94% | 1.054B 29.08% | 971.86M 33.28% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 563.84M 43.11% | 680.18M 33.11% | 736.31M 33.39% | 646.7M 52.52% | 740.96M 31.41% | 882.47M 29.74% | 950.27M 29.06% | 837.22M 29.46% | N/A | N/A | N/A | N/A |
All data in USD
32 analysts have analysed CVNA and the average price target is 429.34 USD. This implies a price increase of 36.57% is expected in the next year compared to the current price of 314.38.
CARVANA CO (CVNA) will report earnings on 2026-05-05.
The consensus EPS estimate for the next earnings of CARVANA CO (CVNA) is 1.47 USD and the consensus revenue estimate is 6.13B USD.
The expected long term growth rate for CARVANA CO (CVNA) is 25.79%.